Search

Your search keyword '"Nair, Gonasagrie"' showing total 51 results

Search Constraints

Start Over You searched for: Author "Nair, Gonasagrie" Remove constraint Author: "Nair, Gonasagrie" Database Unpaywall Remove constraint Database: Unpaywall
51 results on '"Nair, Gonasagrie"'

Search Results

1. Correlates of Adherence to Oral and Vaginal Pre-exposure Prophylaxis (PrEP) Among Adolescent Girls and Young Women (AGYW) Participating in the MTN-034/REACH Trial

2. Digital tools for youth health promotion: principles, policies and practices in sub-Saharan Africa

6. Copper intrauterine device increases vaginal concentrations of inflammatory anaerobes and depletes lactobacilli compared to hormonal options in a randomized trial

8. Post-randomization Differences in Condomless Vaginal Sex Among Women Randomized to Intramuscular Depot Medroxyprogesterone Acetate Injections, a Copper Intrauterine Device or a Levonorgestrel Implant in the ECHO Trial

10. Correlates of Dapivirine Vaginal Ring Acceptance among Women Participating in an Open Label Extension Trial

11. Initiating Intramuscular Depot Medroxyprogesterone Acetate Increases Frequencies of Th17-like Human Immunodeficiency Virus Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial

13. Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

14. Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084

15. The Effect of Contraception on Genital Cytokines in Women Randomized to Copper Intrauterine Device, Depot Medroxyprogesterone Acetate, or Levonorgestrel Implant

16. Cabotegravir for Prevention of HIV-1 in Women: Results From HPTN 084, a Phase III, Randomised Controlled Trial

17. Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis

18. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study

19. Incorporating oral PrEP into standard prevention services for South African women: a nested interrupted time-series study

20. Prevalence and Incidence of Sexually Transmitted Infection in Injectable Progestin Contraception Users in South Africa

21. Prevalent human papillomavirus infection increases the risk of HIV acquisition in African women: advancing the argument for human papillomavirus immunization

22. Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Findings from a randomised, multicentre, open-label trial

23. Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities

24. Weight Change Among Women Using Intramuscular Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: Findings from a Randomised, Multicentre, Open-Label Trial

25. Social harms in female-initiated HIV prevention method research

27. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial

29. Impact of Partner-Related Social Harms on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III Trial

31. HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial

32. Risk Factors for Incidence of Sexually Transmitted Infections Among Women in a Human Immunodeficiency Virus Chemoprevention Trial: VOICE (MTN-003)

33. Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

34. Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

36. Age-Disparate Partnerships and Risk of HIV-1 Acquisition Among South African Women Participating in the VOICE Trial

37. Risk of HIV-1 acquisition among women who use different types of injectable progestin contraception in South Africa: a prospective cohort study

38. Tenofovir-Based Preexposure Prophylaxis for HIV Infection Among African Women

39. Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention

40. Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women

41. Development of a Risk Scoring Tool to Predict HIV-1 Acquisition in African Women

42. Uptake of HBV Vaccination and Incident HBV Infection in Women of Reproductive Age and at Risk of HIV-1 Infection in the VOICE (MTN 003) Study

43. Baseline Characteristics of HIV-1 Negative Women Enrolled into a Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention

44. Prevalent and Incident Gonorrhea and Chlamydia Infections among Oral Contraceptive and Depot Medroxyprogesterone Acetate Users in MTN-003 (VOICE)

45. Age-disparate Partnerships and Risk of HIV-1 Acquisition among South African Women Participating in the VOICE Trial

49. The Immune Reconstitution Inflammatory Syndrome After Antiretroviral Therapy Initiation in Patients With Tuberculosis: Findings From the SAPiT Trial

50. Integration of Antiretroviral Therapy with Tuberculosis Treatment

Catalog

Books, media, physical & digital resources